ERBB2 and neoplasm: By activating downstream oncogenic signaling networks such as PI3K/AKT, MAPK/ERK, and STAT3, HER2 overexpression remodels the tumor microenvironment and induces epithelial-mesenchymal transition (EMT), thereby promoting tumor invasion, metastasis, and treatment resistance.